A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate and to compare the efficacy and safety of FK506MR with Prograf®
in stable liver transplantation patients. It shall be demonstrated that FK506MR is
non-inferior to Prograf® with regards to the efficacy and safety.